Agents of Bioshield: the Fda, Emergency Use Authorizations, and Public Trust
›
Linked as:Extract
Agents of Bioshield: the Fda, Emergency Use Authorizations, and Public Trust
No longer available (Autolink)
See the full content of this document
This document cites
- US Code - 21 U.S.C. § 355-1 Risk Evaluation and Mitigation Strategies
- US Code - 21 U.S.C. § 360bbb-1 Dispute Resolution
- Political and Security Committee Decision (CFSP) 2021/22 of 16 December 2020 on the appointment of the Head of Mission of the European Union CSDP mission in Niger (EUCAP Sahel Niger) (EUCAP Sahel Niger/2/2020)
- Decision No 4/2020 of the ACP-EU Committee of Ambassadors of 22 December 2020 giving a discharge to the Director of the Technical Centre for Agricultural and Rural Cooperation (CTA) in respect of the implementation of its budget for the financial year 2019 [2021/21]
- Council Decision (EU) 2021/3 of 23 November 2020 on the position to be taken, on behalf of the European Union, at the reconvened sixty-third session of the Commission on Narcotic Drugs, on the scheduling of cannabis and cannabis-related substances under the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, and the Convention on Psychotropic Substances of 1971
